The severity of the AHDS clinical phenotype corresponded to the residual transport capacity of the mutated MCT8 protein.[2,8] The type of mutation type may influence the residual transport capacity of MCT8, correlating with the severity of disease manifestations. This evidence concerns the gene SLC16A2 and Allan-Herndon-Dudley syndrome.